Literature DB >> 7683499

Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF--clinical attention.

S Iki, K Yoshinaga, Y Ohbayashi, A Urabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7683499     DOI： 10.1007/bf01703240

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

1.  Acute pulmonary failure after the first administration of recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  R Miniero; E Madon; L Artesani; A Busca; A Sandri; M Aglietta; U Ramenghi
Journal:  Leukemia       Date:  1992-04       Impact factor: 11.528

Review 2.  The Florey Lecture, 1991. The colony-stimulating factors: discovery to clinical use.

Authors:  D Metcalf
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1991-07-29       Impact factor: 6.237

3.  [A phase III study of KRN 8601 (rhG-CSF) on neutropenia induced by chemotherapy for malignant lymphoma--a multi-institutional placebo controlled double-blind comparative study].

Authors:  M Ogawa; T Masaoka; H Mizoguchi; F Takaku; M Nakashima
Journal:  Gan To Kagaku Ryoho       Date:  1990-03

4.  Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.

Authors:  C L Shapiro; B Y Yeap; J Godleski; M S Jochelson; M A Shipp; A T Skarin; G P Canellos
Journal:  Cancer       Date:  1991-08-15       Impact factor: 6.860

5.  Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence.

Authors:  A Yuo; S Kitagawa; A Ohsaka; M Ohta; K Miyazono; T Okabe; A Urabe; M Saito; F Takaku
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113
  5 in total
  10 in total

Review 1.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 2.  Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): a new dimension in immunotherapy.

Authors:  G Schwab; T Hecht
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

Review 3.  Growth factors and hematopoietic recovery.

Authors:  S C Gulati; R Gopal; J B Prowda; S Spanik; M Jain; A Gopal
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

4.  Interstitial pneumonia in patients receiving granulocyte colony-stimulating factor during chemotherapy: survey in Japan 1991-96.

Authors:  N Niitsu; S Iki; K Muroi; S Motomura; M Murakami; H Takeyama; A Ohsaka; A Urabe
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  Drug-Induced Interstitial Lung Disease: A Systematic Review.

Authors:  Sarah Skeoch; Nicholas Weatherley; Andrew J Swift; Alexander Oldroyd; Christopher Johns; Conal Hayton; Alessandro Giollo; James M Wild; John C Waterton; Maya Buch; Kim Linton; Ian N Bruce; Colm Leonard; Stephen Bianchi; Nazia Chaudhuri
Journal:  J Clin Med       Date:  2018-10-15       Impact factor: 4.241

6.  Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice.

Authors:  Shinichiro Kuroshima; Kazunori Nakajima; Muneteru Sasaki; Takashi I; Yoshinori Sumita; Takayuki Asahara; Izumi Asahina; Takashi Sawase
Journal:  Stem Cell Res Ther       Date:  2019-07-16       Impact factor: 6.832

7.  Canadian supportive care recommendations for the management of neutropenia in patients with cancer.

Authors:  C T Kouroukis; S Chia; S Verma; D Robson; C Desbiens; C Cripps; J Mikhael
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677

8.  Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma.

Authors:  N Yokose; K Ogata; H Tamura; E An; K Nakamura; K Kamikubo; S Kudoh; K Dan; T Nomura
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

9.  Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma.

Authors:  K I Lei; W T Leung; P J Johnson
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

10.  Acute respiratory distress syndrome precipitated by granulocyte colony-stimulating factor in undiagnosed Pneumocystis jirovecii pneumonia.

Authors:  Christopher Doig; Rachel Cooke; Chyn Chua; Teresa Leung
Journal:  BMJ Case Rep       Date:  2022-02-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.